| Low-dose MDMA (“ecstasy”) induces vasopressin secretion JA Henry, JK Fallon, AT Kicman, AJ Hutt, DA Cowan, M Forsling The Lancet 351 (9118), 1784, 1998 | 197 | 1998 |
| Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans JK Fallon, AT Kicman, JA Henry, PJ Milligan, DA Cowan, AJ Hutt Clinical Chemistry 45 (7), 1058-1069, 1999 | 175 | 1999 |
| Testosterone measurement by isotope-dilution liquid chromatography–tandem mass spectrometry: validation of a method for routine clinical practice ML Cawood, HP Field, CG Ford, S Gillingwater, A Kicman, D Cowan, ... Clinical chemistry 51 (8), 1472-1479, 2005 | 173 | 2005 |
| High‐dose anabolic steroids in strength athletes: Effects upon hostility and aggression PYL Choi, AC Parrott, D Cowan Human Psychopharmacology: Clinical and Experimental 5 (4), 349-356, 1990 | 170 | 1990 |
| Criteria to indicate testosterone administration. AT Kicman, RV Brooks, SC Collyer, DA Cowan, MN Nanjee, GJ Southan, ... British journal of sports medicine 24 (4), 253-264, 1990 | 128 | 1990 |
| Anabolic steroids detected in bodybuilding dietary supplements–a significant risk to public health V Abbate, AT Kicman, M Evans‐Brown, J McVeigh, DA Cowan, C Wilson, ... Drug Testing and Analysis 7 (7), 609-618, 2015 | 122 | 2015 |
| Detection of ketamine and its metabolites in urine by ultra high pressure liquid chromatography–tandem mass spectrometry MC Parkin, SC Turfus, NW Smith, JM Halket, RA Braithwaite, SP Elliott, ... Journal of Chromatography B 876 (1), 137-142, 2008 | 121 | 2008 |
| Interlaboratory agreement of insulin-like growth factor 1 concentrations measured by mass spectrometry HD Cox, F Lopes, GA Woldemariam, JO Becker, MC Parkin, A Thomas, ... Clinical chemistry 60 (3), 541-548, 2014 | 114 | 2014 |
| Enhanced affinity capture MALDI-TOF MS: orientation of an immunoglobulin G using recombinant protein G H Neubert, ES Jacoby, SS Bansal, RK Iles, DA Cowan, AT Kicman Analytical chemistry 74 (15), 3677-3683, 2002 | 106 | 2002 |
| The effect of 3, 4‐methylenedioxymethamphetamine (MDMA,? ecstasy?) and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus ML Forsling, JK Fallon, D Shah, GS Tilbrook, DA Cowan, AT Kicman, ... British journal of pharmacology 135 (3), 649-656, 2002 | 101 | 2002 |
| Counterfeiting in performance‐and image‐enhancing drugs MR Graham, P Ryan, JS Baker, B Davies, NE Thomas, SM Cooper, ... Drug Testing and Analysis 1 (3), 135-142, 2009 | 98 | 2009 |
| Multidimensional LC-MS/MS enables simultaneous quantification of intact human insulin and five recombinant analogs in human plasma EE Chambers, KJ Fountain, N Smith, L Ashraf, J Karalliedde, D Cowan, ... Analytical chemistry 86 (1), 694-702, 2014 | 96 | 2014 |
| Peptide hormones and sport: misuse and detection AT Kicman, DA Cowan British medical bulletin 48 (3), 496-517, 1992 | 94 | 1992 |
| Misuse of drugs in sport. AH Beckett, DA Cowan British journal of sports medicine 12 (4), 185, 1978 | 92 | 1978 |
| Use of ultra-high pressure liquid chromatography coupled to high resolution mass spectrometry for fast screening in high throughput doping control A Musenga, DA Cowan Journal of Chromatography A 1288, 82-95, 2013 | 91 | 2013 |
| Homocysteine induced cardiovascular events: a consequence of long term anabolic-androgenic steroid (AAS) abuse MR Graham, FM Grace, W Boobier, D Hullin, A Kicman, D Cowan, ... British journal of sports medicine 40 (7), 644-648, 2006 | 84 | 2006 |
| Prediction of chromatographic retention time in high-resolution anti-doping screening data using artificial neural networks TH Miller, A Musenga, DA Cowan, LP Barron Analytical chemistry 85 (21), 10330-10337, 2013 | 82 | 2013 |
| Effect of administration of human chorionic gonadotrophin on criteria used to assess testosterone administration in athletes DA Cowan, AT Kicman, CJ Walker, MJ Wheeler Journal of endocrinology 131 (1), 147-154, 1991 | 82 | 1991 |
| Serum IGF‐I and IGF binding proteins 2 and 3 as potential markers of doping with human GH AT Kicman, JP Miell, JD Teale, J Powrie, PJ Wood, P Laidler, PJ Milligan, ... Clinical endocrinology 47 (1), 43-50, 1997 | 81 | 1997 |
| Pharmacokinetic properties of γ-hydroxybutyrate (GHB) in whole blood, serum, and urine AD Brailsford, DA Cowan, AT Kicman Journal of Analytical Toxicology 36 (2), 88-95, 2012 | 78 | 2012 |
